Literature DB >> 2592966

Magnetic resonance imaging in dementia of Parkinson's disease.

S J Huber1, E C Shuttleworth, J A Christy, D W Chakeres, A Curtin, G W Paulson.   

Abstract

The possibility that dementia in Parkinson's disease is associated with specific cerebral abnormalities identifiable by magnetic resonance imaging (MRI) was examined. Sixty eight patients with Parkinson's disease and 28 age and education matched normal controls were evaluated using neuropsychological procedures that included assessment of language, memory, cognition, visuospatial skills and mood. Twenty three patients (34%) were found to have developed significant impairment in at least three of the five areas, thus meeting criteria for a dementia syndrome. Eleven patients (16%) had no intellectual impairment and thirty four patients (50%) had a mild to moderate intellectual disturbance. Patients with (n = 10) and without dementia (n = 20), matched for severity of Parkinson's disease, and normal controls (n = 10) matched for age with the two patients groups, were evaluated by MRI. MRI scans were analysed for evidence of generalised cerebral atrophy, ventricular enlargement, visualisation of the substantia nigra and severity of focal brain lesions. Results indicated that the presence of dementia in patients with Parkinson's disease was not associated with any specific pattern of MRI abnormalities.

Entities:  

Mesh:

Year:  1989        PMID: 2592966      PMCID: PMC1031629          DOI: 10.1136/jnnp.52.11.1221

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  31 in total

1.  Nuclear magnetic resonance imaging in central nervous system disease.

Authors:  F S Buonanno; J P Kistler; L D DeWitt; K R Davis; R DeLaPaz; P F New; C T Burt; T J Brady
Journal:  Semin Nucl Med       Date:  1983-10       Impact factor: 4.446

2.  Neuropsychological disturbances and cerebral atrophy determined by computerized tomography in parkinsonian patients with long-term levodopa treatment.

Authors:  R Portin; R Raininko; U K Rinne
Journal:  Adv Neurol       Date:  1984

3.  Disturbance of recent memory function in parkinsonian patients on anticholinergic therapy.

Authors:  W C Koller
Journal:  Cortex       Date:  1984-06       Impact factor: 4.027

4.  Interpretation of nuclear magnetic resonance tomograms of the brain.

Authors:  K G Go; P van Dijk; A L Luiten; A A Brouwer-van Herwijnen; I C van der Leeuw; R L Kamman; L M Vencken; J Wilmink; H J Berendsen
Journal:  J Neurosurg       Date:  1983-10       Impact factor: 5.115

5.  Cerebral atrophy in Parkinson's disease--represented in CT.

Authors:  H Becker; E Schneider; H Hacker; P A Fischer
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1979-07-04

6.  Relationship of motor symptoms to intellectual deficits in Parkinson disease.

Authors:  J A Mortimer; F J Pirozzolo; E C Hansch; D D Webster
Journal:  Neurology       Date:  1982-02       Impact factor: 9.910

7.  Is "subcortical dementia" a recognizable clinical entity?

Authors:  R Mayeux; Y Stern; J Rosen; F Benson
Journal:  Ann Neurol       Date:  1983-09       Impact factor: 10.422

8.  The significance of cerebral atrophy for the symptomatology of Parkinson's disease.

Authors:  E Schneider; P A Fischer; P Jacobi; H Becker; H Hacker
Journal:  J Neurol Sci       Date:  1979-07       Impact factor: 3.181

9.  "Tip-of-the-tongue" phenomenon in Parkinson disease.

Authors:  R Matison; R Mayeux; J Rosen; S Fahn
Journal:  Neurology       Date:  1982-05       Impact factor: 9.910

10.  Organic mental syndrome and confusional states in Parkinson's disease. Relationship to computerized tomographic signs of cerebral atrophy.

Authors:  H Sroka; T S Elizan; M D Yahr; A Burger; M R Mendoza
Journal:  Arch Neurol       Date:  1981-06
View more
  10 in total

1.  Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementia.

Authors:  Liana G Apostolova; Mona Beyer; Amity E Green; Kristy S Hwang; Jonathan H Morra; Yi-Yu Chou; Christina Avedissian; Dag Aarsland; Carmen C Janvin; Jan P Larsen; Jeffrey L Cummings; Paul M Thompson
Journal:  Mov Disord       Date:  2010-04-30       Impact factor: 10.338

2.  Hippocampal and ventricular changes in Parkinson's disease mild cognitive impairment.

Authors:  Liana Apostolova; Guido Alves; Kristy S Hwang; Sona Babakchanian; Kolbjorn S Bronnick; Jan Petter Larsen; Paul M Thompson; Yi-Yu Chou; Ole B Tysnes; Hege K Vefring; Mona K Beyer
Journal:  Neurobiol Aging       Date:  2011-08-03       Impact factor: 4.673

Review 3.  Neuropsychological aspects of Parkinson's disease.

Authors:  S A Raskin; J C Borod; J Tweedy
Journal:  Neuropsychol Rev       Date:  1990-09       Impact factor: 7.444

Review 4.  Imaging the adult brain.

Authors:  I Moseley
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-01       Impact factor: 10.154

5.  Examining the relationship between head trauma and neurodegenerative disease: A review of epidemiology, pathology and neuroimaging techniques.

Authors:  Mark H Sundman; Eric E Hall; Nan-Kuei Chen
Journal:  J Alzheimers Dis Parkinsonism       Date:  2014-01-31

6.  Multimodal mechanisms of human socially reinforced learning across neurodegenerative diseases.

Authors:  Agustina Legaz; Sofía Abrevaya; Martín Dottori; Cecilia González Campo; Agustina Birba; Miguel Martorell Caro; Julieta Aguirre; Andrea Slachevsky; Rafael Aranguiz; Cecilia Serrano; Claire M Gillan; Iracema Leroi; Adolfo M García; Sol Fittipaldi; Agustín Ibañez
Journal:  Brain       Date:  2022-04-29       Impact factor: 15.255

7.  Asymmetrical lateral ventricular enlargement in Parkinson's disease.

Authors:  M M Lewis; A B Smith; M Styner; H Gu; R Poole; H Zhu; Y Li; X Barbero; S Gouttard; M J McKeown; R B Mailman; X Huang
Journal:  Eur J Neurol       Date:  2009-04       Impact factor: 6.089

8.  Substantia innominata: MR findings in Parkinson's disease.

Authors:  Hirobumi Oikawa; Makoto Sasaki; Shigeru Ehara; Takashi Abe
Journal:  Neuroradiology       Date:  2004-10       Impact factor: 2.804

9.  A whole-brain analysis in de novo Parkinson disease.

Authors:  C Tessa; M Giannelli; R Della Nave; C Lucetti; C Berti; A Ginestroni; U Bonuccelli; M Mascalchi
Journal:  AJNR Am J Neuroradiol       Date:  2008-01-09       Impact factor: 3.825

10.  Interoception Primes Emotional Processing: Multimodal Evidence from Neurodegeneration.

Authors:  Paula C Salamone; Agustina Legaz; Lucas Sedeño; Sebastián Moguilner; Matías Fraile-Vazquez; Cecilia Gonzalez Campo; Sol Fittipaldi; Adrián Yoris; Magdalena Miranda; Agustina Birba; Agostina Galiani; Sofía Abrevaya; Alejandra Neely; Miguel Martorell Caro; Florencia Alifano; Roque Villagra; Florencia Anunziata; Maira Okada de Oliveira; Ricardo M Pautassi; Andrea Slachevsky; Cecilia Serrano; Adolfo M García; Agustín Ibañez
Journal:  J Neurosci       Date:  2021-04-07       Impact factor: 6.167

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.